Skip to content

Alveolar Ridge Augmentation Using Minimally Invasive Subperiosteal Tunneling With Xenogenic Bone Graft and PRF

Alveolar Ridge Augmentation Using Minimally Invasive Subperiosteal Tunneling With Xenogenic Bone Graft and Platelet-Rich Fibrin: Randomized Controlled Trial

Status
Not yet recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT07079917
Acronym
MISTT
Enrollment
16
Registered
2025-07-23
Start date
2025-08-01
Completion date
2026-06-21
Last updated
2025-07-23

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Alveolar Bone Loss

Brief summary

surgical horizontal augmentation for maxillary alveolar ridge using minimally invasive subperiosteal tunneling in comparison to conventional surgical technique

Interventions

PROCEDUREsubperiosteal tunneling for horizontal alveolar ridge augmentation

subperiosteal dissection through horizontal incision only

PROCEDUREconventional alveolar ridge augmentation

horizontal alveolar ridge augmentation through trapezoidal flap

Sponsors

Fayoum University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Subject)

Eligibility

Sex/Gender
ALL
Age
18 Years to 60 Years
Healthy volunteers
No

Inclusion criteria

* Adults over 18 years old seeking an implant-supported restoration with deficient horizontal posterior maxillary alveolar ridge, at area of one or two missed teeth of less than 5 mm buccolingual width. * Minimum vertical height of 8 mm. * Gingival tissue of healthy adequate keratinization, more than 2mm.

Exclusion criteria

* The presence of uncontrolled diabetes or any other systemic condition which may complicate the surgical procedure or interfere with bone healing * Radiotherapy to the head and neck region * Chemotherapy within the last 12 months * Uncontrolled periodontitis * Smoking * Bisphosphonate therapy * Pregnancy * Presence of periapical infection or lesion

Design outcomes

Primary

MeasureTime frameDescription
Maxillary alveolar bone width6 monthsincrease of the alveolar bone buccolingually for horizontal ridge augmentation

Countries

Egypt

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026